Spago Nanomedical AB - Asset Resilience Ratio

Latest as of December 2016: 54.03%

Spago Nanomedical AB (SPAGO) has an Asset Resilience Ratio of 54.03% as of December 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SPAGO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr43.26 Million

≈ $4.66 Million USD Cash + Short-term Investments

Total Assets

Skr80.06 Million

≈ $8.62 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Spago Nanomedical AB's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Spago Nanomedical AB asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Spago Nanomedical AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read SPAGO total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr43.26 Million	54.03%
Total Liquid Assets	Skr43.26 Million	54.03%

Asset Resilience Insights

Very High Liquidity: Spago Nanomedical AB maintains exceptional liquid asset reserves at 54.03% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Spago Nanomedical AB Industry Peers by Asset Resilience Ratio

Compare Spago Nanomedical AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Spago Nanomedical AB (None–None)

The table below shows the annual Asset Resilience Ratio data for Spago Nanomedical AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Spago Nanomedical AB

ST:SPAGO Sweden Biotechnology

Market Cap

$6.66 Million

Skr61.92 Million SEK

Market Cap Rank

#28087 Global

#617 in Sweden

Share Price

Skr0.09

Change (1 day)

-5.45%

52-Week Range

Skr0.09 - Skr0.33

All Time High

Skr19.04